Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-01-28 @ 10:43 PM
Study NCT ID:
NCT00787605
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2008-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSPP100A2409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
External Affairs
Old Organization:
Novartis